A 12-week supplementation with quercetin does not affect natural killer cell activity, granulocyte oxidative burst activity or granulocyte phagocytosis in female human subjects

Quercetin, a flavonoid found in fruits and vegetables, is a strong antioxidant with anti-inflammatory, antimicrobial and immune-modulating properties. The purpose of the present study was to investigate the effects of long-term quercetin supplementation on innate immune function and inflammation in...

Full description

Saved in:
Bibliographic Details
Published inBritish journal of nutrition Vol. 104; no. 6; pp. 849 - 857
Main Authors Heinz, Serena A., Henson, Dru A., Nieman, David C., Austin, Melanie D., Jin, Fuxia
Format Journal Article
LanguageEnglish
Published Cambridge, UK Cambridge University Press 28.09.2010
Subjects
Online AccessGet full text
ISSN0007-1145
1475-2662
1475-2662
DOI10.1017/S000711451000156X

Cover

More Information
Summary:Quercetin, a flavonoid found in fruits and vegetables, is a strong antioxidant with anti-inflammatory, antimicrobial and immune-modulating properties. The purpose of the present study was to investigate the effects of long-term quercetin supplementation on innate immune function and inflammation in human subjects. Female subjects (n 120; aged 30–79 years) were recruited from the community and randomised to one of three groups, with supplements administered using double-blinded procedures: 500 mg quercetin/d (n 38), 1000 mg quercetin/d (n 40) or placebo (n 42). Subjects ingested two soft chew supplements twice daily during the 12-week study period. Fasting blood samples were obtained pre- and post-study and were analysed for plasma quercetin, IL-6, TNF-α and leucocyte subset cell counts. Natural killer cell activity (NKCA) and lymphocyte subsets were assessed in a subset of seventy-four subjects. Granulocyte oxidative burst activity (GOBA) and phagocytosis were assessed in sixty-four subjects. Eighteen subjects had overlapping data. Quercetin supplementation at two doses compared with placebo increased plasma quercetin (interaction effect; P < 0·001) but had no significant influence on blood leucocyte subsets, plasma IL-6 or TNF-α concentration, NKCA, GOBA or phagocytosis. NKCA was inversely correlated with BMI (r − 0·25; P = 0·035) and body fat percentage (r − 0·38; P = 0·001), and positively correlated with self-reported physical fitness level (r 0·24; P = 0·032). In summary, results from the present double-blinded, placebo-controlled, randomised trial indicated that quercetin supplementation at 500 and 1000 mg/d for 12 weeks significantly increased plasma quercetin levels but had no influence on measures of innate immune function or inflammation in community-dwelling adult females.
Bibliography:http://dx.doi.org/10.1017/S000711451000156X
Abbreviations: FITC, fluorescein isothiocyanate; GOBA, granulocyte oxidative burst activity; NK, natural killer; NKCA, natural killer cell activity; Q-500, 500 mg quercetin/d; Q-1000, 1000 mg quercetin/d; RPMI, Roswell Park Memorial Institute
istex:91449B5394BF6F98BCE5DFE2BC567FC22B7EB505
ark:/67375/6GQ-WB1L7JHG-J
ArticleID:00156
PII:S000711451000156X
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0007-1145
1475-2662
1475-2662
DOI:10.1017/S000711451000156X